Controlled Substances - NAPLEX

Within 7 days. The 7-day requirement ensures documentation follows emergency oral Schedule II orders to comply with DEA accountability standards.

High abuse potential; accepted medical use; severe dependence risk. Schedule II classification under federal law balances recognized therapeutic applications against substantial risks of abuse and dependency.

Moderate-low abuse potential; accepted use; moderate dependence risk. Federal criteria for Schedule III reflect a moderated risk profile compared to higher schedules while acknowledging medical benefits.

Low abuse potential vs Schedule III; limited dependence risk. Schedule IV drugs are designated under the CSA for their reduced abuse liability relative to Schedule III with accepted medical applications.

Lowest abuse potential; accepted use; limited dependence risk. The CSA places substances in Schedule V due to their minimal abuse potential and established medical uses with low dependency risks.

Schedule II. Federal regulations impose the strictest controls on Schedule II substances to mitigate their high abuse and dependence potential.

Schedules III, IV, and V. Lower schedules permit oral prescriptions to facilitate access for substances with reduced abuse and dependence risks.

As authorized by the prescriber. Schedule V's lower abuse risk allows prescriber discretion in refills without strict federal numerical limits.

Within 6 months of the date written. The 6-month refill window for Schedules III and IV ensures prescriptions remain valid only for a reasonable period under federal guidelines.

High abuse potential; no accepted medical use; lack of safety. The Controlled Substances Act classifies drugs into Schedule I based on criteria emphasizing maximum restrictions due to absence of medical utility and elevated risks.

Up to 5 refills. Federal law limits refills for Schedules III and IV to balance access with controls on substances with moderate abuse potential.

Emergency situation; follow-up written/electronic required. Federal exceptions for Schedule II oral orders are limited to emergencies to maintain stringent controls while allowing urgent care.

Only the amount needed during the emergency period. Emergency Schedule II dispensing is restricted to minimal quantities to address immediate needs without enabling excess supply.

Remainder must be filled within 72 hours or forfeited. The 72-hour rule for partial Schedule II fills prevents indefinite holds and reduces diversion risks.

May issue multiple; total up to a $90$-day supply if allowed. DEA permits multiple Schedule II prescriptions for chronic needs, capping total supply to minimize abuse potential.

Schedules III–V: once; Schedule II: no transfers. Transfer rules differentiate schedules to enforce tighter controls on higher-risk substances while allowing flexibility for lower ones.

Schedule II. Non-emergency Schedule II requires written or electronic format to ensure traceability and prevent unauthorized dispensing.

At least 2 years. The 2-year retention supports DEA audits and investigations into controlled substance handling and diversion.

At least every 2 years (biennial inventory). Biennial inventories are mandated by federal law to maintain accurate tracking and detect discrepancies in controlled stock.

Schedules II–V. Secure storage requirements for these schedules aim to prevent theft and diversion under DEA physical security regulations.

Schedule II. Exact counts for Schedule II are required due to their high abuse potential, ensuring precise inventory accountability.

DEA Form 222 (or CSOS electronic equivalent). DEA Form 222 provides a secure, triplicate system for ordering Schedule II to track and prevent diversion.

DEA Form 106. DEA Form 106 facilitates mandatory reporting of losses to enable investigations and maintain supply chain integrity.

DEA Form 224. DEA Form 224 is required for initial registration, ensuring entities meet federal standards for handling controlled substances.